Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horst Koch

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Oncology Reports|November 18, 2004
Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade gliomaPeter Hau, Petra Ruemmele, Leoni A Kunz-Schughart, et al.
Journal of Neuro-Oncology|June 4, 2004
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II studyCaecilia Wismeth, Peter Hau, Klaus Fabel, et al.
Journal of Neuro-Oncology|November 18, 2005
Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomasPeter Hau, Leoni A Kunz-Schughart, Petra Rümmele, et al.
The Breast Journal|July 22, 2014
First experience using contrast-enhanced ultrasound to evaluate vascularisation of acellular dermal matrices after implant-based breast reconstructionDaryousch Parvizi, Franz Haas, Florentia Peintinger, et al.
Surgical Innovation|September 25, 2012
New synthetic prosthesis for peripheral nerve injuries: an experimental pilot studySelman Uranüs, Georg Bretthauer, Doris Nagele-Moser, et al.
European Journal of Clinical Pharmacology|September 28, 2010
Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohortJolanta Majcher-Peszynska, Marko Sass, Sora Schipper, et al.
Cancer|December 12, 2003
Salvage therapy in patients with glioblastoma: is there any benefit?Peter Hau, Ulrike Baumgart, Katharina Pfeifer, et al.
Journal of Clinical Medicine|July 17, 2020
Occult Pathologic Findings in Reduction Mammaplasty in 5781 Patients-An International Multicenter StudyBritta Kuehlmann, Florian D Vogl, Tomas Kempny, et al.
International Journal of Cancer|August 6, 2019
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancerIsabelle Ray-Coquard, David Cibula, Mansoor R Mirza, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Oncology Reports|November 18, 2004
Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade gliomaPeter Hau, Petra Ruemmele, Leoni A Kunz-Schughart, et al.
Journal of Neuro-Oncology|June 4, 2004
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II studyCaecilia Wismeth, Peter Hau, Klaus Fabel, et al.
Journal of Neuro-Oncology|November 18, 2005
Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomasPeter Hau, Leoni A Kunz-Schughart, Petra Rümmele, et al.
The Breast Journal|July 22, 2014
First experience using contrast-enhanced ultrasound to evaluate vascularisation of acellular dermal matrices after implant-based breast reconstructionDaryousch Parvizi, Franz Haas, Florentia Peintinger, et al.
Surgical Innovation|September 25, 2012
New synthetic prosthesis for peripheral nerve injuries: an experimental pilot studySelman Uranüs, Georg Bretthauer, Doris Nagele-Moser, et al.
European Journal of Clinical Pharmacology|September 28, 2010
Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohortJolanta Majcher-Peszynska, Marko Sass, Sora Schipper, et al.
Cancer|December 12, 2003
Salvage therapy in patients with glioblastoma: is there any benefit?Peter Hau, Ulrike Baumgart, Katharina Pfeifer, et al.
Journal of Clinical Medicine|July 17, 2020
Occult Pathologic Findings in Reduction Mammaplasty in 5781 Patients-An International Multicenter StudyBritta Kuehlmann, Florian D Vogl, Tomas Kempny, et al.
International Journal of Cancer|August 6, 2019
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancerIsabelle Ray-Coquard, David Cibula, Mansoor R Mirza, et al.
Pageof 5